{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:18:17Z","timestamp":1790835497474,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jns.2022.120488","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T19:43:12Z","timestamp":1667677392000},"page":"120488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Altered glutamatergic and inflammatory pathways promote glioblastoma growth, invasion, and seizures: An overview"],"prefix":"10.1016","volume":"443","author":[{"given":"Anteneh M.","family":"Feyissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Qui\u00f1ones-Hinojosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120488_bb0005","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jns.2022.120488_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.624145","article-title":"Human cerebrospinal fluid modulates pathways promoting glioblastoma malignancy","volume":"11","author":"Carrano","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jns.2022.120488_bb0015","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1172\/JCI133316","article-title":"Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model","volume":"130","author":"Hatcher","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2022.120488_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/epi.14615","article-title":"Seizures as presenting symptom in patients with glioblastoma","volume":"60","author":"D\u00fchrsen","year":"2019","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2022.120488_bb0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","article-title":"Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article","volume":"111","author":"Chaichana","year":"2009","journal-title":"J Neurosurg."},{"key":"10.1016\/j.jns.2022.120488_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2019.07.026","article-title":"Seizures in glioma patients: an overview of incidence, etiology, and therapies","volume":"404","author":"Samudra","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120488_bb0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/neuonc\/nov269","article-title":"Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy","volume":"18","author":"Armstrong","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jns.2022.120488_bb0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2016.26","article-title":"Seizures and gliomas\u2014towards a single therapeutic approach","volume":"12","author":"Huberfeld","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2022.120488_bb0045","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","article-title":"Mutant IDH1 and seizures in patients with glioma","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120488_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.seizure.2019.05.018","article-title":"Potential influence of IDH1 mutation and MGMT gene promoter methylation on glioma-related preoperative seizures and postoperative seizure control","volume":"69","author":"Feyissa","year":"2019","journal-title":"Seizure."},{"key":"10.1016\/j.jns.2022.120488_bb0055","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1212\/WNL.0000000000005216","article-title":"High-frequency oscillations in awake patients undergoing brain tumor-related epilepsy surgery","volume":"90","author":"Feyissa","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120488_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.jns.2022.120488_bb0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.jns.2022.120488_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nm1772","article-title":"Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema","volume":"14","author":"Savaskan","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2022.120488_bb0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/path.4192","article-title":"Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response","volume":"230","author":"Sielska","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.jns.2022.120488_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.jns.2022.120488_bb0085","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/15384047.2015.1056406","article-title":"Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia\/macrophages and monocyte-derived macrophages","volume":"16","author":"Choi","year":"2015","journal-title":"Cancer Biol Ther."},{"key":"10.1016\/j.jns.2022.120488_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.jns.2022.120488_bb0095","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2022.120488_bb0100","doi-asserted-by":"crossref","first-page":"289ra286","DOI":"10.1126\/scitranslmed.aaa8103","article-title":"SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma","volume":"7","author":"Robert","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jns.2022.120488_bb0105","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2022.120488_bb0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through Neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.jns.2022.120488_bb0115","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.1814932116","article-title":"Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity","volume":"116","author":"Arensman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2022.120488_bb0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12974-016-0727-z","article-title":"Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy","volume":"13","author":"Strauss","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2022.120488_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2012.09.018","article-title":"Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia","volume":"104","author":"Konopka","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jns.2022.120488_bb0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.mayocp.2021.02.019","article-title":"Autoimmune encephalitis-related seizures and epilepsy: diagnostic and therapeutic approaches","volume":"96","author":"Chen","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2022.120488_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106618","article-title":"Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures","volume":"173","author":"Feyissa","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jns.2022.120488_bb0140","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1038\/s41598-020-76982-7","article-title":"Characterization of dysregulated glutamine metabolism in human glioma tissue with (1)H NMR","volume":"10","author":"Ekici","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2022.120488_bb0145","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.0804273106","article-title":"Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion","volume":"106","author":"Markovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2022.120488_bb0150","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/neuonc\/nos116","article-title":"The molecular profile of microglia under the influence of glioma","volume":"14","author":"Li","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jns.2022.120488_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12974-020-01797-2","article-title":"Glioblastoma hijacks microglial gene expression to support tumor growth","volume":"17","author":"Maas","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2022.120488_bb0160","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1038\/s41467-020-18569-4","article-title":"Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression","volume":"11","author":"De Boeck","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2022.120488_bb0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ncb3090","article-title":"Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat. Cell Biol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22003501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22003501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:00:56Z","timestamp":1758384056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22003501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"alternative-id":["S0022510X22003501"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120488","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered glutamatergic and inflammatory pathways promote glioblastoma growth, invasion, and seizures: An overview","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120488"}}